Letter regarding "Evidence-based hyponatremia management in liver disease"
- PMID: 37403318
- PMCID: PMC10577336
- DOI: 10.3350/cmh.2023.0204
Letter regarding "Evidence-based hyponatremia management in liver disease"
Keywords: Brain; Edema; MRI; Myelinolysis; Osmolar derangement.
Conflict of interest statement
The authors have no conflicts to disclose.
Figures
Comment in
-
Correspondence on Letter regarding "Evidence-based hyponatremia management in liver disease".Clin Mol Hepatol. 2023 Oct;29(4):1048-1049. doi: 10.3350/cmh.2023.0261. Epub 2023 Aug 14. Clin Mol Hepatol. 2023. PMID: 37583054 Free PMC article. No abstract available.
Comment on
-
Evidence-based hyponatremia management in liver disease.Clin Mol Hepatol. 2023 Oct;29(4):924-944. doi: 10.3350/cmh.2023.0090. Epub 2023 Jun 5. Clin Mol Hepatol. 2023. PMID: 37280091 Free PMC article. Review.
References
-
- Guevara M, Baccaro ME, Torre A, Gómez-Ansón B, Ríos J, Torres F, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol. 2009;104:1382–1389. - PubMed
-
- Adrogué HJ, Tucker BM, Madias NE. Diagnosis and management of hyponatremia: A review. JAMA. 2022;328:280–291. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
